Modification of the effects of antipsychotic agents on the "open field" performance of rats by treatment with  -methyl tyrosine or p-chlorophenylalanine.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002395:Catecholamines / Q000502:physiology; D002746:Chlorpromazine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004336:Drug Antagonism; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D006120:Grooming / Q000187:drug effects; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology*; D010649:Phenylalanine / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D012701:Serotonin / Q000502:physiology; D013237:Stereoisomerism
D002395:Catecholamines; D008781:Methyltyrosines; D012701:Serotonin; D010649:Phenylalanine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010134:Fenclonine; D002746:Chlorpromazine